| BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian … K Alsop, S Fereday, C Meldrum, A DeFazio, C Emmanuel, J George, ... Journal of clinical oncology 30 (21), 2654-2663, 2012 | 1404 | 2012 |
| Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation TK Wojdacz, A Dobrovic Nucleic acids research 35 (6), e41, 2007 | 660 | 2007 |
| Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization H Do, A Dobrovic Clinical chemistry 61 (1), 64-71, 2015 | 563 | 2015 |
| Methylation of the BRCA1 Gene in Sporadic Breast Cancer A Dobrovic, D Simpfendorfer Cancer research 57 (16), 3347-3350, 1997 | 532 | 1997 |
| A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer JD Mellor, MP Brown, HR Irving, JR Zalcberg, A Dobrovic Journal of hematology & oncology 6, 1-10, 2013 | 375 | 2013 |
| High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer M Krypuy, GM Newnham, DM Thomas, M Conron, A Dobrovic BMC cancer 6, 1-12, 2006 | 375 | 2006 |
| Methylation-sensitive high-resolution melting TK Wojdacz, A Dobrovic, LL Hansen Nature protocols 3 (12), 1903-1908, 2008 | 346 | 2008 |
| Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice M Kansara, M Tsang, L Kodjabachian, NA Sims, MK Trivett, M Ehrich, ... The Journal of clinical investigation 119 (4), 837-851, 2009 | 336 | 2009 |
| Empirical array quality weights in the analysis of microarray data ME Ritchie, D Diyagama, J Neilson, R van Laar, A Dobrovic, A Holloway, ... BMC bioinformatics 7, 1-16, 2006 | 326 | 2006 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 310 | 2015 |
| GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly DL Cameron, J Schröder, JS Penington, H Do, R Molania, A Dobrovic, ... Genome research 27 (12), 2050-2060, 2017 | 309 | 2017 |
| Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma B Devitt, W Liu, R Salemi, R Wolfe, J Kelly, CY Tzen, A Dobrovic, ... Pigment cell & melanoma research 24 (4), 666-672, 2011 | 293 | 2011 |
| High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies H Do, M Krypuy, PL Mitchell, SB Fox, A Dobrovic BMC cancer 8, 1-14, 2008 | 276 | 2008 |
| Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing SQ Wong, J Li, AYC Tan, R Vedururu, JMB Pang, H Do, J Ellul, K Doig, ... BMC medical genomics 7, 1-10, 2014 | 269 | 2014 |
| Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma O Kondrashova, M Topp, K Nesic, E Lieschke, GY Ho, MI Harrell, ... Nature communications 9 (1), 3970, 2018 | 235 | 2018 |
| Distinct clinical and pathological features are associated with the BRAFT1799A (V600E) mutation in primary melanoma W Liu, JW Kelly, M Trivett, WK Murray, JP Dowling, R Wolfe, G Mason, ... Journal of Investigative Dermatology 127 (4), 900-905, 2007 | 229 | 2007 |
| Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value C Stirzaker, E Zotenko, JZ Song, W Qu, SS Nair, WJ Locke, A Stone, ... Nature communications 6 (1), 5899, 2015 | 219 | 2015 |
| Molecular detection of blood‐borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease JE Hardingham, PJ Hewett, RE Sage, JL Finch, JD Nuttall, D Kotasek, ... International journal of cancer 89 (1), 8-13, 2000 | 210 | 2000 |
| Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell … RJ Young, K Waldeck, C Martin, JH Foo, DP Cameron, L Kirby, H Do, ... Pigment cell & melanoma research 27 (4), 590-600, 2014 | 209 | 2014 |
| Sensitive Melting Analysis after Real Time-Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection LS Kristensen, T Mikeska, M Krypuy, A Dobrovic Nucleic acids research 36 (7), e42, 2008 | 206 | 2008 |
